Baaritaanka Degdegga ah ee Isku-dhafka Degdegga ah ee Dhiigga Dahabka ah ee Kolloidal HBsAg&HCV
MACLUUMAADKA SOO SAARKA
| Lambarka Moodeelka | Baaritaanka Isku-dhafka ah ee HBsAg&HCV | Baakad | 20 Tijaabo/xirmo, 30 xirmo/CTN |
| Magaca | Tijaabada Isku-dhafka Degdegga ah ee HBsAg & HCV | Kala soocidda qalabka | Fasalka III |
| Astaamaha | Xasaasiyadda Sare, Hawlgal Fudud | Shahaadada | CE/ ISO13485 |
| Saxnaanta | > 97% | Muddada khaanadaha | Laba Sano |
| Habka cilmi-baarista | Dahabka Kolloidal | Adeegga OEM/ODM | La heli karo |
Sareynta
Waqtiga Tijaabada: 15-20 daqiiqo
Kaydinta: 2-30℃ / 36-86℉
Habka: Dahabka Colloidal
Sifo:
• Xasaasi sare
• natiijada akhrinta 15-20 daqiiqo gudahood
• Hawlgal fudud
• Saxnaan Sare
ISTICMAALKA LOOGU TALAGALAY
Qalabkani wuxuu khuseeyaa ogaanshaha tayada ee fayraska hepatitis B iyo fayraska hepatitisC ee dhiigga aadanaha/plasma/muunadda dhiigga oo dhan, waana ku habboon yahay ogaanshaha dheeraadka ah ee fayraska hepatitis B iyo caabuqyada fayraska hepatitis C, mana ku habboona baaritaanka dhiigga. Natiijooyinka la helay waa in la falanqeeyaa iyadoo lala kaashanayo macluumaadka kale ee caafimaad. cudurka waxaa loogu talagalay in loo isticmaalo xirfadlayaasha caafimaadka oo keliya.
Habka tijaabada
| 1 | Akhri tilmaamaha loogu talagalay isticmaalka iyo si adag u raac tilmaamaha loo baahan yahay ee loogu talagalay isticmaalka si looga fogaado saameynta saxnaanta natiijooyinka baaritaanka |
| 2 | Kahor baaritaanka, qalabka iyo muunadda waxaa laga soo saaraa xaaladda kaydinta waxaana la dheellitiraa heerkulka qolka oo calaamadee. |
| 3 | Jeexitaanka baakadda ee bacda aluminiumka ah, ka soo saar qalabka tijaabada oo calaamadee, ka dibna si toosan u dhig miiska tijaabada. |
| 4 | Muunadda la baarayo (serum/plasma) waxaa lagu daray ceelasha S1 iyo S2 iyadoo la isticmaalayo 2 dhibcood ama muunadda la baarayo (dhiig dhan) ayaa lagu daray ceelasha S1 iyo s2 iyadoo la isticmaalayo 3 dhibcood. Ka dib marka muunadda la geliyo, 1 ilaa 2 dhibcood oo muunad ah ayaa lagu darayaa ceelasha S1 iyo S2,waqtiga ayaa la bilaabay. |
| 5 | Natiijooyinka baaritaanka waa in la fasiraa 15-20 daqiiqo gudahood, haddii natiijooyinka la turjumay ee ka badan 20 daqiiqo aysan ansax ahayn. |
| 6 | Fasiraadda muuqaalka waxaa loo isticmaali karaa fasiraadda natiijooyinka. |
Fiiro gaar ah: muunad kasta waa in lagu shubaa tuubooyin nadiif ah oo la tuuri karo si looga fogaado wasakhowga isdhaafka ah.
BANDHIGGA CAAFIMAADKA
| Natiijooyinka WIZ eeHBsag | Natiijada tijaabada ee fal-galaha tixraaca | Heerka isku-dhacyada togan: 99.48%(95%C.1.97.09%~99.91%) Heerka isku-dhacyada taban: 99.25%(95%C.1.97.32%~99.80%) Wadarta heerka isku-dhaca: 99.35%(95%C1.9810%~99.78%) | ||
| Togan | Taban | Wadarta | ||
| Togan | 190 | 2 | 192 | |
| Taban | 1 | 266 | 267 | |
| Wadarta | 191 | 268 | 459 | |
| Natiijooyinka WIZ eeHCV | Natiijada tijaabada ee fal-galaha tixraaca | Heerka isku-dhacyada togan: 96.55%(95%C1.88.27%~99.05%) Heerka isku-dhacyada taban: 99.50%(95%C.1.98.20%~99.86%) Wadarta heerka isku-dhaca: 99.13%(95%C.1.97.78%~99.66%)
| ||
| Togan | Taban | Wadarta | ||
| Togan | 56 | 2 | 58 | |
| Taban | 2 | 399 | 401 | |
| Wadarta | 58 | 401 | 459 | |
